Related Experiment Video
Updated: Oct 20, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
CKD subpopulations defined by risk-factors: A longitudinal analysis of electronic health records
Rajagopalan Ramaswamy1, Soon Nan Wee1, Kavya George1
1Advanced Analytics, Holmusk, Singapore.
Insights
A new hybrid model identifies chronic kidney disease (CKD) patient subgroups based on risk factor sensitivity. This approach enables personalized treatment strategies to slow disease progression.
Area of Science:
- Biomedical modeling
- Computational biology
- Nephrology
Background:
- Chronic kidney disease (CKD) is progressive and hard to detect early.
- Managing CKD comorbidities is challenging due to complex disease interactions.
- Understanding individual patient progression is key for effective CKD management.
Purpose of the Study:
- To develop a hybrid semimechanistic model for investigating CKD progression.
- To identify patient-specific parameters and segment CKD cohorts.
- To explore cluster-specific treatment strategies for CKD.
Main Methods:
- Developed a hybrid semimechanistic model using ordinary differential equations and neural networks.
- Incorporated complex disease pathways, feedback loops, and medication effects.
- Applied the model to US patient data to derive time-invariant, biologically interpretable parameters.
Main Results:
- The model accurately reproduced biomarker variability in the CKD cohort.
- Clustering identified five subpopulations, four sensitive to specific risk factors (hypertension, hyperlipidemia, hyperglycemia, impaired kidney).
- Simulation studies revealed patient-specific strategies to manage CKD progression.
Conclusions:
- The semimechanistic model effectively identifies CKD progression phenotypes from longitudinal data.
- This approach aids in prioritizing individualized treatment strategies for CKD patients.
- Personalized risk factor management can help restrain or prevent CKD progression.
Abstract:
Chronic kidney disease (CKD) is a progressive disease that evades early detection and is associated with various comorbidities. Although clinical comprehension and control of these comorbidities is crucial for CKD management, complex pathophysiological interactions and feedback loops make this a formidable task. We have developed a hybrid semimechanistic modeling methodology to investigate CKD progression. The model is represented as a system of ordinary differential equations with embedded neural networks and takes into account complex disease progression pathways, feedback loops, and effects of 53 medications to generate time trajectories of eight clinical biomarkers that capture CKD progression due to various risk factors. The model was applied to real world data of US patients with CKD to map the available longitudinal information onto a set of time-invariant patient-specific parameters with a clear biological interpretation. These parameters describing individual patients were used to segment the cohort using a clustering approach. Model-based simulations were conducted to investigate cluster-specific treatment strategies. The model was able to reliably reproduce the variability in biomarkers across the cohort. The clustering procedure segmented the cohort into five subpopulations - four with enhanced sensitivity to a specific risk factor (hypertension, hyperlipidemia, hyperglycemia, or impaired kidney) and one that is largely insensitive to any of the risk factors. Simulation studies were used to identify patient-specific strategies to restrain or prevent CKD progression through management of specific risk factors. The semimechanistic model enables identification of disease progression phenotypes using longitudinal data that aid in prioritizing treatment strategies at individual patient level.
More Related Videos
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Longitudinal Studies
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Chronic Kidney Disease I: Introduction
Longitudinal Research
Mechanistic Models: Compartment Models in Individual and Population Analysis